Researchers have identified 330 potential cancer-driving genes, 74 of which are newly associated with cancer.

The findings highlight the potential to develop new, more targeted treatment options and provide hope that existing cancer treatments, such as PARP inhibitors, could be extended to thousands more patients.

The in-depth analysis of 10,478 cancer genomes across 35 different cancer types, led by scientists at The Institute of Cancer Research, London, revealed that more than 55% of the participants’ tumours may have clinically relevant mutations.

These could predict the patients’ sensitivity or resistance to certain treatments or determine their eligibility for clinical trials. The research, published in Nature Genetics, was funded by Cancer Research UK and several other organisations.

The team analysed genetic data from the UK 100,000 Genomes Project to identify DNA mutations across a broad spectrum of cancer types, including colorectal, breast, lung and uterine cancers.

Overall, ovarian, bladder and bowel cancer had the highest numbers of newly identified driver genes. Notably, genes such as MAP3K21, USP17L22 and TPTE emerged as potentially important genes in the development of bowel, breast and lung cancer, respectively.

Patients whose tumours had mutational profiles related to DNA repair deficiencies, such as homologous recombination deficiency, could benefit from PARP inhibitors – with some already in use for certain breast and ovarian cancers.

Dr Amit Sud, Academic Clinical Lecturer in Genetics and Epidemiology at the ICR at the time of the study, said: “This comprehensive analysis of cancer genomes offers insight into the genetic foundations of cancer and opens potential avenues for treatment.

“While whole-genome sequencing is not yet widely adopted, its future use in clinical practice could improve patient outcomes by offering more personalised treatment plans. Our findings could extend the reach of precision therapies to patients who are not candidates for local or systemic therapies.”

Diana Spencer, Senior Digital Content Editor, DDW